Literature DB >> 31779977

MAGIC biomarkers of acute graft-versus-host disease: Biology and clinical application.

Hrishikesh K Srinagesh1, James L M Ferrara2.   

Abstract

Acute graft-versus-host disease (GVHD) is the major complication of allogeneic hematopoietic cell transplantation and is the primary cause of early non-relapse mortality (NRM) after transplant. GVHD of the gastrointestinal (GI) tract fuels the systemic inflammatory reaction and consequently is the principal driver of mortality. Recently, the MAGIC algorithm probability (MAP) that is computed from two biomarkers of GI GVHD has been validated to accurately predict risk of NRM throughout the course of early acute GVHD. This review focuses on the biology, clinical evidence, and practical application of the biomarkers in the measurement of acute GVHD.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute GVHD; Allogeneic HCT; Biomarkers; GI tract; NRM; Non-relapse mortality

Mesh:

Substances:

Year:  2019        PMID: 31779977      PMCID: PMC6886573          DOI: 10.1016/j.beha.2019.101111

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  26 in total

1.  Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS.

Authors:  Vitor Faca; Marc Coram; Doug Phanstiel; Veronika Glukhova; Qing Zhang; Matthew Fitzgibbon; Martin McIntosh; Samir Hanash
Journal:  J Proteome Res       Date:  2006-08       Impact factor: 4.466

2.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

Authors:  Madan Jagasia; Mukta Arora; Mary E D Flowers; Nelson J Chao; Philip L McCarthy; Corey S Cutler; Alvaro Urbano-Ispizua; Steven Z Pavletic; Michael D Haagenson; Mei-Jie Zhang; Joseph H Antin; Brian J Bolwell; Christopher Bredeson; Jean-Yves Cahn; Mitchell Cairo; Robert Peter Gale; Vikas Gupta; Stephanie J Lee; Mark Litzow; Daniel J Weisdorf; Mary M Horowitz; Theresa Hahn
Journal:  Blood       Date:  2011-10-18       Impact factor: 22.113

Review 3.  The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.

Authors:  G R Hill; J L Ferrara
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

4.  Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.

Authors:  G R Hill; J M Crawford; K R Cooke; Y S Brinson; L Pan; J L Ferrara
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

Review 5.  Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.

Authors:  Robert Zeiser; Bruce R Blazar
Journal:  N Engl J Med       Date:  2017-11-30       Impact factor: 91.245

Review 6.  The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.

Authors:  T P van Staa; H G M Leufkens; C Cooper
Journal:  Osteoporos Int       Date:  2002-10       Impact factor: 4.507

7.  International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

Authors:  Andrew C Harris; Rachel Young; Steven Devine; William J Hogan; Francis Ayuk; Udomsak Bunworasate; Chantiya Chanswangphuwana; Yvonne A Efebera; Ernst Holler; Mark Litzow; Rainer Ordemann; Muna Qayed; Anne S Renteria; Ran Reshef; Matthias Wölfl; Yi-Bin Chen; Steven Goldstein; Madan Jagasia; Franco Locatelli; Stephan Mielke; David Porter; Tal Schechter; Zhanna Shekhovtsova; James L M Ferrara; John E Levine
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-16       Impact factor: 5.742

Review 8.  Graft-versus-host disease.

Authors:  James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Journal:  Lancet       Date:  2009-03-11       Impact factor: 79.321

9.  Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.

Authors:  John E Levine; Sophie Paczesny; Shin Mineishi; Thomas Braun; Sung W Choi; Raymond J Hutchinson; Dawn Jones; Yasser Khaled; Carrie L Kitko; Daniel Bickley; Oleg Krijanovski; Pavan Reddy; Gregory Yanik; James L M Ferrara
Journal:  Blood       Date:  2007-11-27       Impact factor: 22.113

10.  Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease.

Authors:  Dongchang Zhao; Yeung-Hyen Kim; Seihwan Jeong; Joel K Greenson; Mohammed S Chaudhry; Matthias Hoepting; Erik R Anderson; Marcel Rm van den Brink; Jonathan U Peled; Antonio Lc Gomes; Ann E Slingerland; Michael J Donovan; Andrew C Harris; John E Levine; Umut Ozbek; Lora V Hooper; Thaddeus S Stappenbeck; Aaron Ver Heul; Ta-Chiang Liu; Pavan Reddy; James Lm Ferrara
Journal:  J Clin Invest       Date:  2018-09-24       Impact factor: 14.808

View more
  5 in total

1.  Ruxolitinib-corticosteroid as first-line therapy for newly diagnosed high-risk acute graft versus host disease: study protocol for a multicenter, randomized, phase II controlled trial.

Authors:  Liping Dou; Bo Peng; Xin Li; Lu Wang; Mingyu Jia; Lingmin Xu; Fei Li; Daihong Liu
Journal:  Trials       Date:  2022-06-06       Impact factor: 2.728

Review 2.  Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model.

Authors:  Qingxiao Song; Ubaydah Nasri; Defu Zeng
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

Review 3.  Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer.

Authors:  Qianmiao Wu; Huaijun Tu; Jian Li
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

4.  [Chinese consensus of allogeneic hematopoietic stem cell transplantation for hematological disease (Ⅲ) -acute graft-versus-host disease (2020)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-07-14

Review 5.  Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?

Authors:  Giuseppe Lia; Luisa Giaccone; Sarah Leone; Benedetto Bruno
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.